Published May 15, 2019
| Version v1
Journal article
Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
- 1. Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Department of Hematology, Oncology and Respiratory Medicine (Japan)
- 2. Okayama University Hospital, Center for Innovative Clinical Medicine (Japan)
- 3. Okayama University Hospital, Department of Respiratory Medicine (Japan)
Description
Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.
Additional details
Identifiers
Publishing Information
- Journal Title
- International Journal of Clinical Oncology
- Journal Volume
- 24
- Journal Issue
- 5
- Journal Page Range
- p. 461-467
- ISSN
- 1341-9625
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54122137
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; DRUGS; JAPAN; LUNGS; REVIEWS; SMOKES
- Descriptors DEC
- AEROSOLS; ASIA; BODY; COLLOIDS; DEVELOPED COUNTRIES; DISEASES; DISPERSIONS; DOCUMENT TYPES; NEOPLASMS; ORGANS; RESIDUES; RESPIRATORY SYSTEM; SOLS
Optional Information
- Copyright
- Copyright (c) 2019 Japan Society of Clinical Oncology